Northeastern Section of the Drug Metabolism Group (NEDMDG) of the American Chemical Society NEDMDG Summer Symposium, NEDMDG Summer Symposium will be held on Wednesday, June 13, 2012, at the Hoagland-Pincus Conference Center in Shrewsbury, MA. HepatoChem will be exhibiting at this all day event. See you there! http://www.nedmdg.org/events.html
BEVERLY, Mass., Apr 30, 2012 (BUSINESS WIRE) — HepatoChem, Inc. has announced that it has been awarded a $330,000 loan from the Massachusetts Life Sciences Center, a quasi-public agency tasked with implementing the State’s $1 billion Life Sciences Initiative (MLSC). HepatoChem is an early stage life science company with a game changing, proprietary chemistry platform [...]
“HepatoChem (http://www.hepatochem.com/) is a company co-founded in 2008 by Marc Bazin, formerly of Pfizer, and Professor John T. Groves, holder of the Hugh Stott Taylor Chair of Chemistry at Princeton University. HepatoChem was started in the Groves lab at Princeton, but in August 2011 moved to the Biotech InnoVenture Center in Beverly, MA. My interest [...]
Since 2008, HepatoChem offers pharmaceutical and biotech companies reliable and efficient access to small molecule metabolites. Our service will accelerate your drug R&D and reduce costs due to a high rate of drugs attrition.
HepatoChem’s innovative technology uses biomimetic catalysts to mimic the metabolic function of the liver. Its unique technology, developed in collaboration with Professor John Groves laboratory at Princeton University, enables the production of metabolites faster and with greater cost-effectiveness than any other available technology.
HepatoChem technology directly impacts drug discovery by enabling:
HepatoChem is a scientifically driven company combining innovation, fundamental chemistry and industrial processes.
The HepatoChem team offers an expert level of practical experience and know-how in total respect of confidentiality.